Stocks

I was reading one of the articles posted in Finance.sg on Haw Par Corp and decided that its timely to provide an update on the company’s performance in Q2 2013. As mentioned in my article in June, Haw Par Corp is a financially strong company. In terms of asset value, it is currently trading at estimate 31% discount. As of 1 Oct 2013, the net asset value is $10.73 but it share price is only $7.40! This is definitely a value stock with good business fundamentals.

Many Singaporeans can probably relate Haw Par Corp as the manufacturer of the famous Tiger Balm but how many investors know that it also owns the famous Underwater World at Sentosa? I like this company because it had been consistently giving out dividends for the past 20 years. The company is cash rich, is financially strong and is trading at below net asset value. However, this counter has risen in value so much for the past two years that it is beyond my entry price, which is $4.00. Looks like I have to wait until the next stock market crash to load up this overlooked stock in SGX.

The original business of manufacturing and distributing through Southeast Asia pharmaceuticals under the Tiger Brand names, the best known of which is ‘Tiger Balm’, was founded at the turn of the century.

Notwithstanding the bullish market, I decided to compile a list of stocks which I would invest in during crisis times. They would become part of my investment portfolio. These are companies with strong cash flow, sustainable revenue and easy-to-understand businesses. Essentially, these are companies which will still be around 10, 20 and 30 years down the road. I am still doing research and will reveal the companies in due time. Nonetheless, I noted that three of the companies (Genting Singapore, Capitaland and Noble Group) are listed in the STI Index.

Boustead Singapore has risen by 45% for the past 12 months. The P/E and P/Cash flow ratio are estimated by S&P Capital to be 12 and 10.8 respectively. These metrics suggested that the stock is currently expensive. The good thing is that net gearing remains at 0%.

Although this counter seems overvalued, fundamental business prospect still looks good. Boustead Singapore is a global engineering specialist in energy, water infrastructure, industrial real estate and geo-spatial solutions.

The main driver for the business is the real estate division, which contribute 24% to its top line in Q1FY14 to SGD101.2 million. Oil and gas division is the second main contributor, reporting revenue growth of 38% year-to-year. Water infrastructure and geo-spatial technology were the weaker divisions, reporting negative revenue growth of 25% and 14% respectively.

I like Boustead because it is financially strong with net current assets of $150 million. The company has consistently paid out dividends to shareholders for the last ten years and it is well-managed with sound corporate strategies. Although Boustead has no formal dividend policy, it has a tradition of paying dividends linked to long-term net profit growth.  Boustead has achieved respectable growth in dividends over the past ten years, with a compounded annual growth rate of 21% over that period.

Below is an article from guest blogger, Richard who works as a stock analyst and has 3 years of experience in the stock market. He likes to write articles and hope to share his experiences with investors in Singapore If you would like additional SGX Dividend Stocks data, information or screening tools, please visit website http://sg.dividendinvestor.com, a leading source for in-depth research and analysis for stock investments. 

Singapore has many advantages of investing money. It’s strongly pro-business environment provides an efficient infrastructure and a transparent administration. The economy of Singapore is committed to free market development and free trade. The investors who are looking for Singapore Dividends these stocks will be helpful for them. 

Hafary Holdings Ltd (SGX: 5VS)

Biosensors continues to see strong, double~djgit sales growth in EMEA and Asia Pacific regions. Sales of critical care products remained constant at US$3.4 million in the quarter ended 30 June 2013, compared to US$3,3 million in the previous year’s corresponding quarter.

Total revenue, including licensing and royalty revenue, for the quarter decreased 11% to US$76.6 million from US$86.3 million in the previous year’s corresponding quarter. The table below shows the Group’s revenue and the principal components of the revenue, as a percentage of total revenue, for the periods indicated:

Cost of sales and gross profit:
Overall gross margin for products was 75% for the quarter ended 30 June 2013, compared to 81% for the previous year’s corresponding quarter.

I read an article in The Strait Times which stated that SingTel was grilled by investors over its digital investments during its latest annual general meeting AGM. Apparently, some of the investors were concerned about the company’s decision to budget multi-billion dollar for its new digital investments and queried the company on the soundness of such an ambitious plan. I am not vested in any SingTel shares and neither did I attend any of its AGM, but after reading the article, I have some comments.

Most investors thought that buying the shares of a company means having a stake in the entity, albeit as minor shareholders. They are absolutely right. But technically, in most cases, they do not have much say or influence over key decisions made by the management of the company.

Take for example, in SingTel’s case, even though many minor shareholders were unhappy over the company’s strategy to invest billion of dollars in digital portals, the resolution was still passed. So honestly, I would say the AGM was really just a formality to inform the outcome of management’s decision.

My thinking is that if you are uncomfortable with the direction undertook by the company which you invested in, you should just divest away your stake.

Below is an article from guest blogger, Richard who works as a stock analyst and has 3 years of experience in the stock market. He likes to write articles and hope to share his experiences with investors in Singapore If you would like additional SGX Dividend Stocks data, information or screening tools, please visit website http://sg.dividendinvestor.com, a leading source for in-depth research and analysis for stock investments.

While talking about the Singapore stocks outlook, we should examine the general global economic outlook. As being a small country the Singapore stock market is much shaped by what is going on in the global markets. By investing in Singapore Stocks, investors can generate income for their future. I am sharing five Singapore stocks from Industrial sector in which you should invest.

MYP Ltd (SGX: F86)

Below is an article from guest blogger, Richard who works as a stock analyst and has 3 years of experience in the stock market. He likes to write articles and hope to share his experiences with investors on Singapore stocks. If you would like additional Singapore stocks data, information or screening tools, please visit website http://sg.dividendinvestor.com, a leading source for in-depth research and analysis for stock investments. 

Singapore is the fourth largest foreign exchange trading center which is also rated as the most business-friendly economy in the world. The country had an estimated growth rate of 8.2% for the second quarter of 2007. The country has many financial advantages. It has also a strong currency. Focus on these Singapore stocks to add your portfolio.

SembCorp Marine Ltd. (SGX: S51)

1) Read the first two and last two paragraphs of the CEO/Chairman’s statements. This will give you an idea of the company’s performances. Do the same for management’s discussions and operational analysis.

2) Check if independent auditors gave a clean bill of health.

3) Look at the financial statements in the annual report and check for the following:
i) Check if the net profits for the last 5 years are rising or falling. In general, avoid investing in businesses with new direction or in the midst of a turnaround because the risk of losing your investment is very high.

Many Singaporeans can probably relate Haw Par Corp as the manufacturer of the famous Tiger Balm but how many investors know that it also owns the famous Underwater World at Sentosa? I like this company because it had been consistently giving out dividends for the past 20 years. The company is cash rich, is financially strong and is trading at below net asset value.

However, this counter has risen in value so much for the past two years that it is beyond my entry price, which is $4.00. Looks like I have to wait until the next stock market crash to load up this overlooked stock in SGX.

Biosensors announced a set of good results. Below is a short write-up on this SGX-listed company.

Quick Glance 
1) Net Profit: US$115milliom
2) Cash and cash equivalent: US$614million
3) Net current asset: US$688million
4) Long term borrowing: US$277million
5) Net cash from operation: US$123million
6) Net asset value per share: US$0.72

Performance Summary for FY13  
For the full year FY13, total revenue was US$336.2 million, a 15% increase from the fiscal year ended 31 March 2012 (FY12). Total product revenue was US$278.5 million, a 32% year-on-year increase while IVP revenue rose 35% year-on-year to US$264.9 million, primarily driven by growth in the Company’s DES sales and the consolidation of JWMS’ financial results starting from the third quarter of FY12 (Q3 FY12). CCP revenue was US$13.6 million, a 7% decrease from US$14.6 million in FY12. Licensing and royalties revenue was US$57.7 million, down US$23.1 million or 29% from US$80.8 million in FY12.

Gross margin on total product sales was 81% for FY13, a significant improvement from 73% in FY12 attributable to more favorable geographical and product mix as well as greater economies of scale.
Total operating expenses accounted for 57% of product revenue in FY13, compared to 61% for FY12.

Dividend History
Although Boustead has no formal dividend policy, it has a tradition of paying dividends linked to long-term net profit growth.  Boustead has achieved respectable growth in dividends over the past ten years, with a compounded annual growth rate of 21% over that period.

Their history of annual dividend payments includes:
1)Ten consecutive years of dividend payments;
2) Growth in the ordinary dividend to 5 cents per share in FY2012 after maintaining the ordinary dividend at 4 cents per share for four consecutive years; and
3) Paying a total of 33.75 cents in cash dividends over ten consecutive years, equivalent to almost 200% of the purchase price of the Boustead share at 17 cents at the beginning of FY2003.

Dividend Stock
My decision to sell off k1 Ventures is not because of the stock performance. In fact, it has always delivered consistent good corporate results because it is well managed by a team of experienced management. Since 2005, it has been giving out dividends and returning capital reductions to its investors. I stand corrected, but any investors who bought this stock in 2005 would have gotten back their principle capital.

I invested in YHM, formerly known as China Enersave, since 2008. Recently, I noted that it is currently one of the top traded stock in Singapore stock market. I would like to share with my readers my investment experience on this stock.

Back in 2008, China Enersave was a company that specialized in building and operating biomass generation plants in China. The business model was good as it collected waste biomass from farmers in China and used the waste as feedstock to generate electricity.

Because of these factors, coupled with the financial crisis in 2008-2009, the company was on the brink of being liquidated in 2011.

The company had received only 77.62% of the total number of issued shares, way below the required 90% for the proposal to go through.

Extension of offer closing date
I was quite annoyed with GKB Holdings for extending the offer closing date TWICE. I thought the management of GKB Holdings was quite disrespectful to the minority shareholders when they extended the offer closing date without even improving the offer.

Being a long-term investor and loyal supporter of the company, I am disappointed with this recent turn of events.